Incorporating Commercial and Private Data into an Open Linked Data Platform for Drug Discovery

Carole Goble, Alasdair J. G. Gray, Lee Harland, Karen Karapetyan, Antonis Loizou, Ivan Mikhailov, Yrjänä Rankka, Stefan Senger, Valery Tkachenko, Antony J. Williams, Egon L. Willighagen
  • January 2013, Springer Science + Business Media
  • DOI: 10.1007/978-3-642-41338-4_5

Incorporating Commercial and Private Data into a Semantic Web Platform for Drug Discovery

What is it about?

The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected.

Why is it important?

In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.

Read Publication

http://dx.doi.org/10.1007/978-3-642-41338-4_5

The following have contributed to this page: Dr Antony John Williams and Dr Egon Willighagen